Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Food Chem Toxicol ; 148: 111917, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-33296712

RESUMEN

A case-control design determined whether konzo, an upper motoneuron disease linked to food (cassava) toxicity was associated with protein carbamoylation and genetic variations. Exon sequences of thiosulfate sulfurtransferase (TST) or mercaptopyruvate sulfurtransferase (MPST), plasma cyanide detoxification rates, and 2D-LC-MS/MS albumin carbamoylation were assessed in 40 children [21 konzo-affected and 19 putatively healthy controls, mean (SD) age: 9.2 (3.0) years] subjected to cognition and motor testing using the Kaufman Assessment Battery and the Bruininks/Oseretsky Test, respectively. Konzo was significantly associated with higher levels of carbamoylated peptides 206-219 (LDELRDEGKASSAK, pep1) after adjusting for age, gender, albumin concentrations and BUN [regression coefficient: 0.03 (95%CI:0.02-0.05), p = 0.01]. Levels of pep1 negatively correlated with performance scores at all modalities of motor proficiency (r = 0.38 to 0.61; all p < 0.01) or sequential processing (memory)(r = - 0.59, p = 0.00) and overall cognitive performance (r = - 0.48, p = 0.00) but positively with time needed for cyanide detoxification in plasma (r = 0.33, p = 0.04). Rare potentially damaging TST p.Arg206Cys (rs61742280) and MPST p.His317Tyr (rs1038542246) heterozygous variants were identified but with no impact on subject phenotypes. Protein carbamoylation appears to be a reliable marker for cassava related neurodegeneration.


Asunto(s)
Manihot/envenenamiento , Carbamilación de Proteína , Albúmina Sérica Humana/análisis , Secuencia de Aminoácidos , Estudios de Casos y Controles , Niño , Disfunción Cognitiva/sangre , Disfunción Cognitiva/epidemiología , Disfunción Cognitiva/genética , República Democrática del Congo , Femenino , Enfermedades Transmitidas por los Alimentos , Humanos , Masculino , Modelos Moleculares , Enfermedad de la Neurona Motora/sangre , Enfermedad de la Neurona Motora/epidemiología , Enfermedad de la Neurona Motora/genética , Polimorfismo de Nucleótido Simple , Albúmina Sérica Humana/metabolismo , Sulfurtransferasas/genética , Tiosulfato Azufretransferasa/genética
2.
Rev Neurol (Paris) ; 175(10): 631-640, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31542178

RESUMEN

The consumption by humans of plants with potential to induce neurological disorders is widespread, but overt disease surfaces only when the subject's toxic threshold is exceeded. Excessive intake arising from food dependency in the setting of hunger, chronic undernutrition, vitamin deficiency, inadequate detoxication, or other individual susceptibility, can trigger acute encephalopathy (lychee, ackee fruits), sub-acute spastic paraparesis (grasspea, cassava root/leaves) or ataxic neuropathy (cassava root flour). While these disorders are very rarely encountered in high-income countries, they are not only common among impoverished populations but also often occur as outbreaks that impact a significant proportion of an affected community. Unfamiliarity with the adverse effects of plant toxins has sometimes led to the mistaken attribution of nutritional neurotoxic disease to a neurotropic viral or synthetic pesticidal etiology. The combination of human population growth, food and water insecurity, poverty and, with climate change, increased dependency on environmentally tolerant plants with neurotoxic potential, predictably may result in an increased prevalence of nutritional neurotoxic disorders, especially in certain parts of Africa and Asia.


Asunto(s)
Desnutrición/complicaciones , Enfermedades del Sistema Nervioso/inducido químicamente , Síndromes de Neurotoxicidad/etiología , Plantas/toxicidad , Blighia/efectos adversos , Susceptibilidad a Enfermedades , Humanos , Litchi/efectos adversos , Desnutrición/epidemiología , Manihot/efectos adversos , Manihot/toxicidad , Enfermedades del Sistema Nervioso/epidemiología , Enfermedades del Sistema Nervioso/etiología , Síndromes de Neurotoxicidad/epidemiología , Intoxicación por Plantas/complicaciones , Intoxicación por Plantas/epidemiología , Áreas de Pobreza
3.
Neurotoxicology ; 59: 256-262, 2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-27246648

RESUMEN

Using a matched case-control design, we sought to determine whether the odds of konzo, a distinct spastic paraparesis associated with food (cassava) cyanogenic exposure in the tropics, were associated with lower cyanide detoxification rates (CDR) and malnutrition. Children with konzo (N=122, 5-17 years of age) were age- and sex-matched with presumably healthy controls (N=87) and assessed for motor and cognition performances, cyanogenic exposure, nutritional status, and cyanide detoxification rates (CDR). Cyanogenic exposure was ascertained by thiocyanate (SCN) concentrations in plasma (P-SCN) and urine (U-SCN). Children with a height-for-age z-score (HAZNCHS)<-2 were classified as nutritionally stunted. CDR was measured as time required to convert cyanide to SCN, and expressed as ms/µmol SCN/mg protein or as mmolSCN/ml plasma/min. Mean (SD) U-SCN in children with konzo was 521.9 (353.6) µmol/l and was, significantly higher than 384.6 (223.7) µmol/l in those without konzo. Conditional regression analysis of data for age- and sex- matched case-control pairs showed that konzo was associated with stunting (OR: 5.8; 95% CI: 2.7-12.8; p<0.01; N=83 paired groups) and higher U-SCN (OR: 1.1; 95% CI: 1.02-1.20 per 50-µmol increase in U-SCN; p=0.02; N=47 paired groups). After adjusting for stunting and U-SCN, the odds of developing konzo was reduced by 63% (95% CI: 11-85%, p=0.03; N=41 paired groups) for each 5mmol SCN/(ml plasma/min)-increase in CDR. Linear regression analysis indicated a significant association between BOT-2 or KABC-II scores and both the HAZNCHS z-score and the U-SCN concentration, but not the CDR. Our findings provide evidence in support of interventions to remove cyanogenic compounds from cassava prior to human consumption or, peharps, enhance the detoxification of cyanide in those relying on the cassava as the main source of food.


Asunto(s)
Cianuros/toxicidad , Paraparesia Espástica Tropical/inducido químicamente , Sulfurtransferasas/metabolismo , Adolescente , Análisis de Varianza , Estudios de Casos y Controles , Niño , Preescolar , Trastornos del Conocimiento/etiología , Femenino , Humanos , Masculino , Trastornos Motores/etiología , Nitrilos , Paraparesia Espástica Tropical/metabolismo , Estudios Retrospectivos , Estadísticas no Paramétricas
4.
Metab Brain Dis ; 29(2): 359-66, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24481810

RESUMEN

While risk factors for konzo are known, determinants of cognitive impairment in konzo-affected children remain unknown. We anchored cognitive performance (KABC-II scores) to serum levels of free-thyroxine (free-T4), thyroid-stimulating hormone (TSH), albumin, and motor proficiency (BOT-2 scores) in 40 children including 21 with konzo (median age: 9 years) and 19 without konzo (median age: 8 years). A multiple regression model was used to determine variables associated with changes in KABC-II scores. Age (ß: -0.818, 95% CI: -1.48, -0.152) (p = 0.018), gender (ß: -5.72; 95% CI: -9.87, -1.57 for females) (p = 0.009), BOT-2 score (ß: 0.390; 95% CI: 0.113, 0.667) (p = 0.008), and free-T4 (ß: 1.88; 95% CI: 0.009, 3.74) (p = 0.049) explained 61.1 % of variation in KABC-II scores. Subclinical hypothyroidism was not associated with poor cognition. A crude association was found between serum albumin and KABC-II scores (ß: 1.26; 95 % CI: 0.136, 2.39) (p = 0.029). On spot urinary thiocyanate reached 688 µmol/l in children without konzo and 1,032 µmol/L in those with konzo. Female gender and low serum albumin are risk factors common to cognitive and proportionally associated motor deficits in children exposed to cassava cyanogens. The two types of deficits may share common mechanisms.


Asunto(s)
Trastornos de la Nutrición del Niño/diagnóstico , Cognición/fisiología , Cianuros/efectos adversos , Manihot/efectos adversos , Nitrilos/efectos adversos , Paraparesia Espástica Tropical/diagnóstico , Niño , Trastornos de la Nutrición del Niño/epidemiología , Trastornos de la Nutrición del Niño/etiología , Cognición/efectos de los fármacos , Cianuros/administración & dosificación , Femenino , Humanos , Masculino , Nitrilos/administración & dosificación , Paraparesia Espástica Tropical/epidemiología , Paraparesia Espástica Tropical/etiología , Desempeño Psicomotor/efectos de los fármacos , Desempeño Psicomotor/fisiología
5.
Acta Neuropathol ; 109(4): 405-10, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15759132

RESUMEN

The aromatic gamma-diketone 1,2-diacetylbenzene (1,2-DAB), the putative active metabolite of the organic solvent 1,2-diethylbenzene, forms blue-colored polymeric protein adducts and induces the formation of amyotrophic lateral sclerosis (ALS)-like giant, intraspinal neurofilamentous axonal swellings in Sprague Dawley rats. The pathogenetic mechanism of this neuropathy has yet to be understood. We assessed whether these pathological changes are also seen in the C57BL/6 mouse, the animal of choice for toxicogenomic studies. Mice were treated intraperitoneally with 30, 35, 50, or 70 mg/kg 1,2-DAB or its inactive isomer 1,3-DAB per day (or on alternate days) for up to 43 days. Animals treated with 30 or 35 mg/kg per day 1,2-DAB, but not with 1,3-DAB, developed muscle spasms and progressive weakness, most prominently in hind limbs. Light microscopy revealed swollen axons in spinal anterior horns and proximal ventral roots, and to a lesser extent in dorsal root ganglia of 1,2-DAB-treated animals. Ultrastructural examination of swollen axons revealed clumps of maloriented 10-nm neurofilaments. Sciatic nerves showed clustering of axonal microtubules and other organelles. These findings are qualitatively comparable to those reported in rats treated with 1,2-DAB and represent a suitable phenotype with which to explore molecular mechanisms of proximal, giant neurofilamentous axonopathy using proteomic and genomic technologies.


Asunto(s)
Acetofenonas/toxicidad , Esclerosis Amiotrófica Lateral/inducido químicamente , Esclerosis Amiotrófica Lateral/patología , Axones/efectos de los fármacos , Modelos Animales de Enfermedad , Esclerosis Amiotrófica Lateral/fisiopatología , Animales , Axones/patología , Axones/ultraestructura , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Masculino , Ratones , Ratones Endogámicos C57BL , Microscopía Electrónica de Transmisión/métodos , Distribución Aleatoria , Médula Espinal/efectos de los fármacos , Médula Espinal/patología , Médula Espinal/ultraestructura , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...